Is Pseudohypoparathyroidism hereditary?

TL;DR: Yes, Pseudohypoparathyroidism is a hereditary condition caused by genetic mutations that prevent the body from responding properly to parathyroid hormone. It is primarily inherited in an autosomal dominant pattern, meaning an affected parent has a 50% chance of passing the genetic variant to each of their children, though cases can also arise from spontaneous, de novo mutations.

Is Pseudohypoparathyroidism hereditary or genetic?

Pseudohypoparathyroidism (PHP) is both genetic and hereditary. It is "genetic" because it is caused by specific mutations in the DNA—most commonly within the GNAS gene—which disrupt the body’s signaling pathways. It is "hereditary" because these mutations are typically passed from parent to child through germline transmission. However, it is important to understand that the clinical expression of Pseudohypoparathyroidism can be complex due to a phenomenon called genomic imprinting, where the activity of the gene depends on whether it was inherited from the mother or the father.

What is the inheritance pattern of Pseudohypoparathyroidism?

The inheritance of Pseudohypoparathyroidism follows an autosomal dominant pattern. This means that a single copy of the altered gene, inherited from either parent, is sufficient to cause the condition. Because of the imprinting mechanism mentioned above, the specific subtype of Pseudohypoparathyroidism that a child develops (such as PHP-Ia or PHP-Ib) often correlates with the parent of origin. For example, in PHP-Ia, if the mutation is inherited from the mother, the child typically exhibits both hormonal resistance and Albright hereditary osteodystrophy (AHO) features, whereas paternal inheritance may result in AHO features without the hormonal resistance.

Are de novo mutations common in this condition?

While many cases of Pseudohypoparathyroidism are inherited from an affected parent, de novo mutations—spontaneous genetic changes that occur for the first time in the affected individual—are also well-documented. In these instances, neither parent carries the mutation, and the occurrence is not linked to family history. Whether the case is familial or de novo, the clinical management remains focused on addressing the underlying hormone resistance and electrolyte imbalances characteristic of Pseudohypoparathyroidism.

How is genetic testing and counseling utilized?

Genetic testing is the gold standard for confirming a diagnosis of Pseudohypoparathyroidism and identifying the specific subtype. Testing involves molecular analysis of the GNAS gene. Genetic counseling is strongly recommended for all families affected by Pseudohypoparathyroidism to help navigate the following:

• Risk Assessment: Calculating the 50% recurrence risk for future pregnancies in affected individuals.


• Family Screening: Identifying other family members who may be asymptomatic carriers or have undiagnosed mild symptoms.


• Reproductive Options: Discussing prenatal diagnosis or preimplantation genetic testing (PGT) for families who wish to understand the genetic status of a pregnancy.


• Understanding Imprinting: Clarifying how the parent-of-origin effect influences the clinical presentation of Pseudohypoparathyroidism within the family tree.

Our community at DiseaseMaps.org currently includes 42 people with Pseudohypoparathyroidism who share their experiences, and we encourage you to seek support from this network while working with your clinical team.

Next steps

• Consult with a clinical geneticist to discuss whether genetic testing is appropriate for you or your family members.


• Schedule an appointment with an endocrinologist who has specific experience managing patients with Pseudohypoparathyroidism.


• Connect with the 42 members of our community at DiseaseMaps.org to share insights and coping strategies.


• Request a referral to a genetic counselor to map out your family history and discuss reproductive planning.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Pseudohypoparathyroidism.


• Orphanet: Pseudohypoparathyroidism (ORPHA:748).


• OMIM (Online Mendelian Inheritance in Man): GNAS gene and PHP-related disorders.


• National Organization for Rare Disorders (NORD): Pseudohypoparathyroidism entry.